Jiangxi Fushine Pharmaceutical Co Ltd (300497) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.008x

Based on the latest financial reports, Jiangxi Fushine Pharmaceutical Co Ltd (300497) has a cash flow conversion efficiency ratio of 0.008x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥18.31 Million ≈ $2.68 Million USD) by net assets (CN¥2.17 Billion ≈ $317.24 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Jiangxi Fushine Pharmaceutical Co Ltd - Cash Flow Conversion Efficiency Trend (2011–2024)

This chart illustrates how Jiangxi Fushine Pharmaceutical Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read Jiangxi Fushine Pharmaceutical Co Ltd debt and liabilities for a breakdown of total debt and financial obligations.

Jiangxi Fushine Pharmaceutical Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Jiangxi Fushine Pharmaceutical Co Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
NRW Holdings Limited F:3NR	0.169x
CBIZ Inc NYSE:CBZ	0.013x
FLEX LNG Ltd NYSE:FLNG	0.040x
Beijing VRV Software Corp Ltd SHE:300352	0.012x
Hefei Jianghang Aircraft Equipment Corporation Ltd SHG:688586	-0.030x
Zhejiang Jiangshan Chemical Co Ltd SHE:002061	0.111x
Beijing Hotgen Biotech Co Ltd SHG:688068	0.001x
dentalcorp Holdings Ltd TO:DNTL	0.037x

Annual Cash Flow Conversion Efficiency for Jiangxi Fushine Pharmaceutical Co Ltd (2011–2024)

The table below shows the annual cash flow conversion efficiency of Jiangxi Fushine Pharmaceutical Co Ltd from 2011 to 2024. For the full company profile with market capitalisation and key ratios, see 300497 company net worth.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	CN¥2.18 Billion ≈ $318.55 Million	CN¥187.64 Million ≈ $27.46 Million	0.086x	+428.84%
2023-12-31	CN¥2.47 Billion ≈ $361.55 Million	CN¥-64.76 Million ≈ $-9.48 Million	-0.026x	+41.66%
2022-12-31	CN¥2.69 Billion ≈ $393.58 Million	CN¥-120.85 Million ≈ $-17.68 Million	-0.045x	-280.87%
2021-12-31	CN¥2.91 Billion ≈ $426.02 Million	CN¥72.32 Million ≈ $10.58 Million	0.025x	-80.20%
2020-12-31	CN¥3.05 Billion ≈ $445.98 Million	CN¥382.35 Million ≈ $55.95 Million	0.125x	-43.29%
2019-12-31	CN¥1.53 Billion ≈ $223.52 Million	CN¥337.91 Million ≈ $49.45 Million	0.221x	+44.20%
2018-12-31	CN¥1.15 Billion ≈ $167.80 Million	CN¥175.91 Million ≈ $25.74 Million	0.153x	-29.62%
2017-12-31	CN¥966.71 Million ≈ $141.46 Million	CN¥210.72 Million ≈ $30.84 Million	0.218x	-9.34%
2016-12-31	CN¥784.17 Million ≈ $114.75 Million	CN¥188.53 Million ≈ $27.59 Million	0.240x	+93.69%
2015-12-31	CN¥596.21 Million ≈ $87.24 Million	CN¥74.01 Million ≈ $10.83 Million	0.124x	+12.02%
2014-12-31	CN¥283.26 Million ≈ $41.45 Million	CN¥31.39 Million ≈ $4.59 Million	0.111x	-55.50%
2013-12-31	CN¥229.76 Million ≈ $33.62 Million	CN¥57.22 Million ≈ $8.37 Million	0.249x	-27.25%
2012-12-31	CN¥184.60 Million ≈ $27.01 Million	CN¥63.20 Million ≈ $9.25 Million	0.342x	+22.08%
2011-12-31	CN¥120.52 Million ≈ $17.64 Million	CN¥33.80 Million ≈ $4.95 Million	0.280x	--

About Jiangxi Fushine Pharmaceutical Co Ltd

SHE:300497 China Biotechnology

Market Cap

$1.52 Billion

CN¥10.41 Billion CNY

Market Cap Rank

#7322 Global

#1741 in China

Share Price

CN¥19.32

Change (1 day)

-2.57%

52-Week Range

CN¥8.37 - CN¥21.15

All Time High

CN¥24.76